$804 Million is the total value of HARVARD MANAGEMENT CO INC's 47 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 4.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOOGL | Buy | Alphabet Inccap stk cl a | $230,664,000 | -12.2% | 2,411,540 | +1900.0% | 28.70% | -5.7% |
| FB | Meta Platforms Inccl a | $154,121,000 | -15.9% | 1,135,916 | 0.0% | 19.18% | -9.6% | |
| SGMS | Light & Wonder Inc | $114,857,000 | -8.7% | 2,678,571 | 0.0% | 14.29% | -1.9% | |
| ABCL | Abcellera Biologics Inc | $40,599,000 | -7.1% | 4,105,095 | 0.0% | 5.05% | -0.2% | |
| EQRX Inc | $26,048,000 | +5.5% | 5,262,161 | 0.0% | 3.24% | +13.4% | ||
| Buy | Grab Holdings Limitedclass a ord | $24,463,000 | +80.1% | 9,301,490 | +73.2% | 3.04% | +93.5% | |
| PCT | Purecycle Technologies Inc | $20,160,000 | +8.8% | 2,498,170 | 0.0% | 2.51% | +16.9% | |
| RXRX | Recursion Pharmaceuticals Incl a | $16,058,000 | +30.7% | 1,509,254 | 0.0% | 2.00% | +40.5% | |
| RVMD | Revolution Medicines Inc | $13,220,000 | +1.2% | 670,382 | 0.0% | 1.64% | +8.7% | |
| RLAY | Relay Therapeutics Inc | $12,105,000 | +33.6% | 541,124 | 0.0% | 1.51% | +43.6% | |
| PLRX | Pliant Therapeutics Inc | $11,748,000 | +160.8% | 562,379 | 0.0% | 1.46% | +180.1% | |
| Meli Kaszek Pioneer Corpclass a ord | $9,870,000 | -0.3% | 1,000,000 | 0.0% | 1.23% | +7.2% | ||
| ASML | ASML Holding N V | $8,384,000 | -12.7% | 20,186 | 0.0% | 1.04% | -6.2% | |
| QRVO | Qorvo Inc | $8,312,000 | -15.8% | 104,669 | 0.0% | 1.03% | -9.5% | |
| NVDA | Nvidia Corporation | $8,056,000 | -19.9% | 66,368 | 0.0% | 1.00% | -14.0% | |
| ADI | Analog Devices Inc | $7,604,000 | -4.6% | 54,568 | 0.0% | 0.95% | +2.5% | |
| TSM | Taiwan Semiconductor Mfg Ltdsponsored ads | $7,356,000 | -16.1% | 107,294 | 0.0% | 0.92% | -9.9% | |
| AMAT | Applied Matls Inc | $7,246,000 | -10.0% | 88,443 | 0.0% | 0.90% | -3.2% | |
| AMD | Advanced Micro Devices Inc | $7,105,000 | -17.1% | 112,137 | 0.0% | 0.88% | -11.0% | |
| LRCX | Lam Research Corp | $7,002,000 | -14.1% | 19,131 | 0.0% | 0.87% | -7.7% | |
| KNTE | Kinnate Biopharma Inc | $5,951,000 | -5.2% | 498,001 | 0.0% | 0.74% | +1.8% | |
| MU | Micron Technology Inc | $5,387,000 | -9.4% | 107,522 | 0.0% | 0.67% | -2.6% | |
| INTC | Intel Corp | $5,354,000 | -31.1% | 207,752 | 0.0% | 0.67% | -26.0% | |
| TXG | 10X Genomics Inc | $5,301,000 | -37.1% | 186,143 | 0.0% | 0.66% | -32.3% | |
| NRIX | Nurix Therapeutics Inc | $4,101,000 | +2.8% | 314,762 | 0.0% | 0.51% | +10.4% | |
| Rocket Lab Usa Inc | $4,070,000 | +7.4% | 1,000,000 | 0.0% | 0.51% | +15.3% | ||
| FULC | Fulcrum Therapeutics Inc | $3,323,000 | +65.2% | 410,714 | 0.0% | 0.41% | +77.3% | |
| AFRM | Affirm Hldgs Inc | $3,256,000 | +3.9% | 173,560 | 0.0% | 0.40% | +11.6% | |
| CFLT | Confluent Inc | $3,099,000 | +2.3% | 130,383 | 0.0% | 0.39% | +10.0% | |
| SANA | Sana Biotechnology Inc | $2,812,000 | -6.7% | 468,749 | 0.0% | 0.35% | +0.3% | |
| GBIO | Generation Bio Co | $2,710,000 | -19.1% | 510,354 | 0.0% | 0.34% | -13.1% | |
| Vigil Neuroscience Inc | $2,634,000 | +252.6% | 289,460 | 0.0% | 0.33% | +281.4% | ||
| Tango Therapeutics Inc | $2,564,000 | -20.1% | 708,385 | 0.0% | 0.32% | -14.2% | ||
| PCTTW | Purecycle Technologies Inc*w exp 03/17/202 | $2,429,000 | +28.3% | 714,285 | 0.0% | 0.30% | +37.9% | |
| Tenaya Therapeutics Inc | $1,952,000 | -48.5% | 673,270 | 0.0% | 0.24% | -44.6% | ||
| New | Nauticus Robotics Inc. | $1,805,000 | – | 500,000 | +100.0% | 0.22% | – | |
| PRAX | Praxis Precision Medicines Inc | $1,767,000 | -7.3% | 778,517 | 0.0% | 0.22% | -0.5% | |
| Surrozen Inc | $1,670,000 | -31.3% | 826,852 | 0.0% | 0.21% | -26.0% | ||
| DYN | Dyne Therapeutics Inc | $1,362,000 | +84.8% | 107,252 | 0.0% | 0.17% | +98.8% | |
| PACB | Pacific Biosciences Calif Inc | $1,330,000 | +31.3% | 229,144 | 0.0% | 0.16% | +41.0% | |
| Xilio Therapeutics Inc | $1,211,000 | -0.3% | 416,059 | 0.0% | 0.15% | +7.1% | ||
| DBTX | Decibel Therapeutics Inc | $1,138,000 | -17.8% | 328,798 | 0.0% | 0.14% | -11.2% | |
| LAUR | New | Laureate Education Inc | $1,074,000 | – | 101,804 | +100.0% | 0.13% | – |
| MCRB | Seres Therapeutics Inc | $846,000 | +87.2% | 131,847 | 0.0% | 0.10% | +101.9% | |
| Pardes Biosciences Inc | $740,000 | -39.7% | 400,000 | 0.0% | 0.09% | -35.2% | ||
| MGTA | Magenta Therapeutics Inc | $469,000 | +17.5% | 332,610 | 0.0% | 0.06% | +26.1% | |
| GMTX | Gemini Therapeutics Inc | $410,000 | -3.1% | 250,000 | 0.0% | 0.05% | +4.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 34 | Q3 2021 | 19.4% |
| VANGUARD TAX-MANAGED INTL FD | 34 | Q3 2021 | 14.0% |
| VANGUARD INTL EQUITY INDEX F | 34 | Q3 2021 | 12.2% |
| SPDR GOLD TRUST | 34 | Q3 2021 | 8.7% |
| ISHARES TR | 34 | Q3 2021 | 4.9% |
| META PLATFORMS INC | 29 | Q3 2023 | 37.6% |
| VANGUARD SPECIALIZED PORTFOL | 28 | Q1 2020 | 2.8% |
| MAGENTA THERAPEUTICS INC | 21 | Q2 2023 | 1.4% |
| ALPHABET INC | 19 | Q3 2023 | 30.4% |
| ISHARES TR | 19 | Q3 2021 | 4.4% |
View HARVARD MANAGEMENT CO INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NuCana plc | February 12, 2021 | 1,678,239 | 3.3% |
| ADURO BIOTECH, INC. | February 08, 2019 | 640,595 | 0.8% |
| Fortress Transportation & Infrastructure Investors LLCSold out | July 08, 2016 | 0 | 0.0% |
| Alpha Security Group CORP | February 13, 2009 | 436,300 | 5.8% |
| BLOCKBUSTER INC | February 13, 2009 | 5,567,100 | 7.7% |
| ChinaGrowth North Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
| ChinaGrowth South Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
| GENEVA ACQUISITION CORPSold out | February 13, 2009 | 0 | 0.0% |
| Ideation Acquisition Corp. | February 13, 2009 | 310,200 | 2.5% |
| MBF Healthcare Acquisition Corp. | February 13, 2009 | 1,220 | 0.0% |
View HARVARD MANAGEMENT CO INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View HARVARD MANAGEMENT CO INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.